Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | USNA USANA Health Sciences, Inc. | ABBV AbbVie |
|---|---|---|
| Price | $14.37 -0.7% | $259.93 -0.6% |
| StockIQ Score | 39F Weak Risk: High | 48D+ Moderate Risk: High |
| Technical | 26F | 41D |
| Fundamental | 50C- | 57C |
| Growth | 34F | 34F |
| Fair Value | 38F | 33F |
| News | 56C | 98A+ |
| Quality | 42D | 42D |
| Risk | 40D | 44D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
AbbVie outperforms USANA in overall investor confidence, scoring 48 versus 39, and has a stronger "MODERATE" rating compared to USANA’s "WEAK." AbbVie also leads in technical scoring (41 vs. 26) and fundamental scoring (57 vs. 50), though both share the same growth score of 34. USANA’s valuation score (38) slightly edges out AbbVie’s (33).
